{"keywords": [{"value": "Bristol Myers Squibb Company", "rank": "1", "is_major": "Y", "name": "organizations"}, {"value": "Food and Drug Administration", "rank": "2", "is_major": "Y", "name": "organizations"}, {"value": "Skin Cancer", "rank": "3", "is_major": "Y", "name": "subject"}, {"value": "Drugs (Pharmaceuticals)", "rank": "4", "is_major": "Y", "name": "subject"}, {"value": "Melanomas", "rank": "5", "is_major": "N", "name": "subject"}], "headline": {"kicker": "Business Briefing", "print_headline": "Fda Approves Combining Two Cancer-Fighting Drugs ", "content_kicker": "Business Briefing", "main": "F.D.A. Approves Combining 2 Cancer-Fighting Drugs"}, "byline": {"contributor": "", "organization": "THE ASSOCIATED PRESS", "original": "By THE ASSOCIATED PRESS", "person": []}, "web_url": "http://www.nytimes.com/2015/10/02/business/fda-approves-combining-2-cancer-fighting-drugs.html", "source": "The New York Times", "subsection_name": null, "slideshow_credits": null, "type_of_material": "Brief", "_id": "560dcddc38f0d81aa77a5214", "multimedia": [], "pub_date": "2015-10-02T00:00:00Z", "print_page": "2", "section_name": "Business Day", "word_count": "138", "blog": [], "news_desk": "Business", "snippet": "The first combination of drugs to bolster the immune system to fight cancer has been approved, giving Bristol-Myers Squibb an early lead over competitors.", "document_type": "article", "abstract": "Food and Drug Administration approves two new skin cancer drugs from Bristol-Myers Squibb; drugs Opdivo and Yervoy work by bolstering immune system.", "lead_paragraph": "The first combination of drugs to bolster the immune system to fight cancer has been approved, giving Bristol-Myers Squibb an early lead over competitors."}